selected publications
-
Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health.
The American journal of pathology.
2019
Review
GET IT
Times cited: 16 -
Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection.
JCI insight.
2018
Academic Article
GET IT
Times cited: 41 -
The Microbiome and Tuberculosis: Early Evidence for Cross Talk.
mBio.
2018
Review
GET IT
Times cited: 49 -
Mycobacterial Mutagenesis and Drug Resistance Are Controlled by Phosphorylation- and Cardiolipin-Mediated Inhibition of the RecA Coprotease.
Molecular cell.
2018
Academic Article
GET IT
Times cited: 12 -
Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.
Scientific reports.
2017
Academic Article
GET IT
Times cited: 105 -
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
Microbiome.
2017
Academic Article
GET IT
Times cited: 81 -
Unraveling Cholesterol Catabolism in Mycobacterium tuberculosis: ChsE4-ChsE5 α2β2 Acyl-CoA Dehydrogenase Initiates β-Oxidation of 3-Oxo-cholest-4-en-26-oyl CoA.
ACS infectious diseases.
2015
Academic Article
GET IT
Times cited: 49